ADPT Stock Ownership Activity
ADAPTIVE BIOTECHNOLOGIES 13F holders
No value investing guru has made any change to the ADAPTIVE BIOTECHNOLOGIES (ADPT) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying ADPT now?
According to the latest SEC filing(s) ADAPTIVE BIOTECHNOLOGIES (ADPT) has not been purchased by any super investor.
To see more about who is investing in ADAPTIVE BIOTECHNOLOGIES (ADPT), please go to the ADPT ownership page.
2020 Q4
(1 result)
Current price: $4.43
92.51%
Reported price*: $59.13
2020 Q1
(1 result)
Current price: $4.43
84.05%
Reported price*: $27.78
2019 Q2
(1 result)
Current price: $4.43
90.83%
Reported price*: $48.30
3 of 3
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.